A Trauma-Informed, Clinical Framework for Addiction Assessment
This article is part of The PMHNP Guide to Addiction Psychiatry, a clinical education series exploring how Psychiatric Mental Health Nurse Practitioners assess, diagnose, and treat substance use disorders using evidence-based, trauma-informed care.
When a patient comes in and substance use is part of their story, a Psychiatric Mental Health Nurse Practitioner approaches the assessment with one core principle: curiosity, not judgment. Addiction is deeply tied to trauma, neurobiology, mental health, and the patient’s lived experiences — not moral failure.
A PMHNP evaluates:
Safety First (Medical, Psychiatric, and Withdrawal Risk)
- Risk of alcohol or benzodiazepine withdrawal
- Risk for overdose
- Recent mixing of substances
- Suicidal ideation with intoxication
- Co-occurring medical instability (HTN crisis, arrhythmias, infection)
Mental Health Comorbidities
Most patients don’t just have “addiction.” Often it’s intertwined with:
- PTSD
- Anxiety disorders
- ADHD
- Bipolar disorder
- Depression
- Personality disorders
A PMHNP’s lens is always biopsychosocial — not just “substance use.”
Trauma History & Emotional Triggers
A PMHNP assesses:
- childhood trauma
- attachment wounds
- recent losses
- emotional dysregulation patterns
- coping skills
Substance use often functions as emotional anesthetic — a survival strategy, not a choice.
Patterns of Use
A PMHNP explores:
- frequency
- route
- quantity
- motivation (“What do you get from it?”)
- progression
- withdrawal symptoms
- tolerance
The goal isn’t to interrogate — it’s to understand.
Stage of Change
Is the patient:
- pre-contemplative?
- contemplative?
- ambivalent?
- ready?
A PMHNP meets the patient where they are, not where others want them to be.
Treatment Opportunities
Depending on needs, PMHNPs may recommend:
- MAT (Suboxone, Naltrexone, etc.)
- psychiatric medications
- therapy referrals
- IOP/PHP
- trauma work
- harm reduction strategies
The PMHNP perspective is compassionate, whole-person, and rooted in the belief that people heal when they feel safe and understood.
PMHNPs evaluate addiction through a biopsychosocial and trauma-informed lens, considering safety, mental health, trauma history, and substance-use patterns together.
Withdrawal risks, overdose potential, suicidal ideation, and medical instability can be life-threatening and must be addressed before long-term treatment planning.
No. Addiction is understood as a neurobiological and trauma-related condition, not a moral failure.
Many individuals use substances to cope with unresolved trauma, emotional dysregulation, or attachment wounds, which must be addressed for recovery to succeed.
It means respecting the patient’s stage of change and readiness, rather than forcing abstinence or treatment prematurely.